| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_199450d8e2d705a2b559ce4c32e5dcb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d4de83c0a1e0f05165b4c374ec6ae44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_070787d818d3cfd7bb8a6b67b2c58788
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_294e567850b28682b56038b743b32435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5ddfbe14c0fbf9e847e35fed96f03f4f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y102-01 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-04 |
| filingDate |
2012-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a5a12fa1721c0f3c8d8540c4802b62b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44bba952a6b86a14ba6a749582a4135e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fae56cf1d8928abb84bb81a4ec3e99ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a2ff5becc173faceccf8f2b45f5e30 |
| publicationDate |
2016-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9309546-B2 |
| titleOfInvention |
Genetically modified cell and process for use of said cell |
| abstract |
The present invention relates to the field of biotransformation of furanic compounds. More particular the present invention relates to novel genetically modified cells with improved characteristics for biocatalytic transformation of furanic compounds and a vector suitable for the genetic modification of a host cell. Further aspects of the invention are aimed at processes for biotransformation of 5-(hydroxymethyl)furan-2-carboxylic acid (HMF-acid) and its precursors with the use of the cell according to the invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9828616-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016257978-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10023890-B2 |
| priorityDate |
2011-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |